These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6491932)

  • 1. Synthesis of Methyl 2,3-bis(hydroxymethyl)-5-phenyl-7-oxabicyclo[2.2.1]hepta-2,5-diene- 6-carboxylate bis(N-methylcarbamate) derivatives as potential antitumor agents.
    Anderson WK; Mulumba B
    J Pharm Sci; 1984 Aug; 73(8):1182-3. PubMed ID: 6491932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allylic esters as potential antitumor agents. Derivatives and analogues of 2,3-bis(hydroxymethyl)-7-oxabicyclo[2.2.1]hept-2-ene.
    Anderson WK; Dewey RH; Mulumba B
    J Med Chem; 1979 Oct; 22(10):1270-2. PubMed ID: 513076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileukemic activity of derivatives of 1,2-dimethyl-3,4-bis(hydroxymethyl)-5-phenylpyrrole bis(N-methylcarbamate).
    Anderson WK; Halat MJ
    J Med Chem; 1979 Aug; 22(8):977-80. PubMed ID: 490542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antileukemic activity of 1-methyl-2,5-diphenyl-3,4-bis(hydroxymethyl)-, 1,2,3-triphenyl-4,5-bis(hydroxymethyl)-, and 1-methyl-2,3-diphenyl-4,5-bis(hydroxymethyl)pyrrole bis(N-methylcarbamate).
    Anderson WK; Halat MJ; Rick AC
    J Med Chem; 1980 Jan; 23(1):87-9. PubMed ID: 7359518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of furan, thiophene, and azole bis[(carbamoyloxy)methyl] derivatives as potential antineoplastic agents.
    Anderson WK; Jones AN
    J Med Chem; 1984 Dec; 27(12):1559-65. PubMed ID: 6502590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship studies of cytotoxic epoxide derivatives of 7-oxabicyclo[2.2.1]heptane.
    Anderson WK; Dewey RH
    J Med Chem; 1977 Feb; 20(2):306-8. PubMed ID: 836504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and murine antineoplastic activity of bis[(carbamoyloxy)methyl] derivatives of pyrrolo[2,1-a]isoquinoline.
    Anderson WK; McPherson HL; New JS; Rick AC
    J Med Chem; 1984 Oct; 27(10):1321-5. PubMed ID: 6481769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, chemical reactivity, and antileukemic activity of 5-substituted 6,7-bis(hydroxymethyl)pyrrolo[1,2-c]thiazole biscarbamates and the corresponding sulfoxides and sulfones.
    Anderson WK; Mach RH
    J Med Chem; 1987 Nov; 30(11):2109-15. PubMed ID: 3669018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, antineoplastic activity, and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethyl)imidazole.
    Anderson WK; Bhattacharjee D; Houston DM
    J Med Chem; 1989 Jan; 32(1):119-27. PubMed ID: 2909723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of bicyclo[3.3.1]nonenol derivatives.
    Geirsson JK; Jonsson S; Valgeirsson J
    Bioorg Med Chem; 2004 Nov; 12(21):5563-9. PubMed ID: 15465333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Phenyl-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-cis-amine derivatives with hypotensive and other activities.
    Bondavalli F; Ranise A; Schenone P; Mariani E; Marfella A; Campidonico U; D'Angelo G; Marmo E
    Farmaco Sci; 1982 Mar; 37(3):159-70. PubMed ID: 7067811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological activity of 6-aryl-2-azabicyclo[4.2.1]nonanes.
    Mazzocchi PH; Kim CH
    J Med Chem; 1982 Dec; 25(12):1473-6. PubMed ID: 7154008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antileukemic activity of bis[[(carbamoyl)oxy]methyl]- substituted pyrrolo[2,1-a]isoquinolines, pyrrolo[1,2-a]quinolines, pyrrolo[2,1-a]isobenzazepines, and pyrrolo[1,2-a]benzazepines.
    Anderson WK; Heider AR; Raju N; Yucht JA
    J Med Chem; 1988 Nov; 31(11):2097-102. PubMed ID: 3184121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3,3-Trimethyl-N-(2-pyridyl)-2-oxabicyclo[2.2.2]octan-6-amine derivatives with hypotensive and other activities.
    Mariani E; Bruno O; Schenone P; De Santis D; Di Mauro G; Marmo E
    Farmaco Sci; 1986 Jun; 41(6):454-63. PubMed ID: 3743741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, evaluation of chemical reactivity, and murine antineoplastic activity of 2-hydroxy-5-(3,4-dichlorophenyl)-6,7-bis(hydroxymethyl)-2,3-dihydro-1H- pyrrolizine bis(2-propylcarbamate) and 2-acyloxy derivatives as potential water-soluble prodrugs.
    Anderson WK; Chang CP; McPherson HL
    J Med Chem; 1983 Sep; 26(9):1333-8. PubMed ID: 6887210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antineoplastic activity of bis[[[(alkylamino)carbonyl]oxy]methyl]-substituted 3-pyrrolines as prodrugs of tumor inhibitory pyrrole bis(carbamates).
    Anderson WK; Milowsky AS
    J Med Chem; 1986 Nov; 29(11):2241-9. PubMed ID: 3783586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of amino derivatives of 9,10-ethanoanthracene and 7-oxabicyclo(2.2.1)heptene.
    Kolodyńska Z; Wieniawski W
    Acta Pol Pharm; 1975; 32(2):133-7. PubMed ID: 1136820
    [No Abstract]   [Full Text] [Related]  

  • 18. Aminoethers of (+)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]-octan-6-hydroxyimine with hypotensive activity. II.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Filippelli A; Marrazzo R; Di Guglielmo R; Marmo E
    Farmaco Sci; 1986 Aug; 41(8):630-6. PubMed ID: 2874996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esters of 1,3,3-trimethyl-6-cis-piperidino-2-oxabicyclo[2.2.2]octan-5-cis-ol endowed with hypotensive activity.
    Longobardi M; Ranise A; Bondavalli F; Schenone P; Filippelli W; Filippelli A; Berrino L; Marmo E
    Farmaco Sci; 1983 Feb; 38(2):81-9. PubMed ID: 6840269
    [No Abstract]   [Full Text] [Related]  

  • 20. N-phenyl 1,3,3-trimethyl-2-oxabicyclo[2,2,2]octan-6-cis-amine derivatives with hypotensive activity II.
    Bondavalli F; Schenone P; Ranise A; Filippelli W; Bile G; Filippelli A; Marmo E
    Farmaco Sci; 1983 Jan; 38(1):57-66. PubMed ID: 6825832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.